Teleflex announced U.S. FDA 510(k) clearance of the Ringer Perfusion Balloon Catheter, the only commercially available Percutaneous Transluminal Coronary Angioplasty perfusion balloon. The Ringer Perfusion Balloon Catheter will enter a limited market release phase in August of 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TFX:
- Teleflex Expands Interventional Cardiology Portfolio with FDA 510(k) Clearance of the Ringer™ Perfusion Balloon Catheter
- Teleflex (TFX) Q2 Earnings Cheat Sheet
- Teleflex awarded Hemostasis Products agreements with Premier
- Teleflex Awarded Hemostasis Products Agreements with Premier, Inc.
- Teleflex Announces the Teleflex Center for Antimicrobial Protection